CPMS | NEWSLETTER | ERN
HealthFlex
×
  • Home
  • The Network
    • Who We Are
    • Our Vision, Mission & Aim
    • Structure & Governance
    • Specialised Centres
    • Coordinators
    • Stakeholders & Supporters
    • Informative Materials
  • For Patients
    • Patient Board
    • Find a specialist centre
    • Patient Organisations
    • Patient Resources
    • Cross-border Healthcare
  • Expertise
    • Evaluation
    • Education Programme
    • Guidelines
    • UIMD Registry
    • Subnetworks
    • Work Packages
    • Transversal Activities
    • CPMS Support
    • Resources
  • News & Events
    • News
    • Events
  • Activities
    • Projects
    • Publications
  • Contact Us

EJP RD workshop – The Blood-Brain Barrier: current research and novel therapeutic crossing approaches

EJP RD workshop – The Blood-Brain Barrier: current research and novel therapeutic crossing approaches
EducationEducation for ProfessionalsEvents

“The Blood-Brain Barrier: current research and novel therapeutic crossing approaches” workshop will be hosted at the University of Padua, Italy, 8-9 June 2023. The training workshop is funded by the European Joint Programme on Rare Diseases (EJP RD) and organized by the MetabERN Coordinator, Prof. Maurizio Scarpa (Azienda Sanitaria Universitaria Friuli Centrale) with the kind contribution of Prof. Alessandra Biffi (University of Padua).

Concept
The normal functioning of the brain and the central nervous system is protected by the blood-brain barrier (BBB), which tightly regulates the brain homeostasis. Built to protect and preserve the correct functioning of the brain by avoiding the entrance of potentially damaging molecules, the BBB also prevents small and large therapeutic compounds from efficiently reaching the brain in case of disease. Indeed, the delivery of therapeutics to the brain cells faces many challenges that hinder the development and testing of novel therapies for brain and neurological disorders. Despite this, various strategies are currently being developed to improve the delivery of small and large molecules to the brain.

Aim
The workshop will provide an overview of recent research and key issues regarding neurodegenerative disorders and the blood-brain barrier (BBB), as a starting point to stimulate discussion on these topics and identify novel opportunities for basic, clinical, and translational research activities on the BBB. As an outcome, the workshop aims to foster new collaborations between participants and other scientists to generate working groups for the development of BBB-crossing therapies for rare diseases.

Registration

The participation to the workshop is free of charge and to register please fill the application form here until the 19th March 2023. Interested participants need to be affiliated to an ERN-Full Member or Affiliated Partner institution and will be informed if they are selected to attend this training course by the end of March 2023.

Search

Last News & Events

  • Liver Transplant for Inborn Errors of Metabolism – Sharing Knowledge Across ERNs
  • 6th World Conference on CDG – 21-23 July 2023
  • Gyrate Atrophy of the Choroid and Retina – International hybrid symposium
  • 2023 CTX International Scientific Meeting in Jerusalem
  • Postgraduate Course on Lysosomal Storage Disorders in Nierstein
  • EVALUATING THE DIRECT AND INDIRECT COSTS OF FABRY DISEASE IN ITALY
  • EJP RD workshop – The Blood-Brain Barrier: current research and novel therapeutic crossing approaches
  • Patient representatives for Smith-Lemli-Opitz syndrome are looking for European families

Activities

  • Publications and Guidelines
  • Unified Registry for Inherited Metabolic Disorders
  • Projects

Disclaimer

MetabERN is a European Reference Network (ERN) approved by the ERN Board of Member States.
The ERNs are co-funded by the European Commission.
For more information about the ERNs and the EU health strategy, please visit ec.europa.eu/health/ern
The content on this website represents the views of the network and is its sole responsibility; it can in no way be taken to reflect the views of the European Commission or any other body of the European Union.

For more information please contact
Prof. Maurizio Scarpa, MD, PhD
MetabERN Coordinator

Newsletter

Sign up to the MetabERN newsletter

Follow us on Twitter

Tweets by @Metab_ERN

Search the website


Copyright ©2017-2021 all rights reserved
Previous Content

Web by EFFIGE 2.0
To provide the best possible service, we use technical, statistical and third-party cookies on this site. Continuing the navigation you consent to use them. Accept Reject Read More
Privacy & Cookies Policy

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Non-necessary
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.
SAVE & ACCEPT